By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exonhit today said that Almac Diagnostics will serve as the sole reference laboratory for testing performed with Exonhit's AclarusDx for Alzheimer's disease.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.